DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Loibl S, Untch M, Burchardi N. et al
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple negative breast cancer – clinical results and biomarker analysis of GeparNuevo study.

Ann Oncol 2019; pii: mdz158
DOI: 10.1093/annonc/mdz158.

Download Bibliographical Data

Search in: